{"id":708,"date":"2026-05-14T16:20:42","date_gmt":"2026-05-14T15:20:42","guid":{"rendered":"http:\/\/seamlessbio.de\/?page_id=708"},"modified":"2026-06-27T12:06:49","modified_gmt":"2026-06-27T11:06:49","slug":"malaria-tropical-disease-research","status":"publish","type":"page","link":"https:\/\/seamlessbio.de\/de\/malaria-tropical-disease-research\/","title":{"rendered":"Application Malaria Research"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"708\" class=\"elementor elementor-708\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-233273f e-con e-atomic-element e-flexbox-base e-e25744d \" data-id=\"233273f\" data-element_type=\"e-flexbox\" data-e-type=\"e-flexbox\" data-interaction-id=\"233273f\" data-e-type=\"e-flexbox\" data-id=\"233273f\">\n    \t\t<div class=\"elementor-element elementor-element-f620a44 elementor-widget elementor-widget-html\" data-id=\"f620a44\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!-- YOAST SEO SETTINGS\nSlug:             applications\/malaria-tropical-disease-research\nFocus Keyword:    malaria Plasmodium falciparum culture human serum AB\nSEO Title (EN):   Malaria & Tropical Disease Research \u2014 Human Serum AB for P. falciparum Culture | SeamlessBio\nMeta Desc (EN):   Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, AlbuMAX comparison. Lot reservation. SeamlessBio.\n-->\n<section class=\"sb-mal\">\n<style>\n.sb-mal,.sb-mal*,.sb-mal*::before,.sb-mal*::after{box-sizing:border-box;}\n.sb-mal{background:#fff;padding:70px 40px 90px;font-family:Arial,sans-serif;color:#202020;}\n.sb-mal .wrap{max-width:1200px;width:100%;margin:0 auto;}\n.sb-mal .bc{display:flex;flex-wrap:wrap;gap:8px;margin:0 0 24px;color:#777;font-size:14px;}\n.sb-mal .bc a{color:#18b7b2!important;text-decoration:none!important;font-weight:700;}\n.sb-mal .bc strong{color:#111;font-weight:800;}\n\/* HERO *\/\n.sb-mal .hero{padding:64px 56px;margin-bottom:48px;border-radius:30px;background:linear-gradient(135deg,#18b7b2 0%,#65d3cf 52%,#e9fbfa 100%);color:#fff;}\n.sb-mal .hero .ey{display:inline-block;margin-bottom:14px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:1.8px;}\n.sb-mal .hero h1{margin:0 0 18px;color:#fff;font-size:clamp(26px,3.2vw,40px);line-height:1.1;font-weight:900;letter-spacing:-1px;max-width:840px;}\n.sb-mal .hero .sub{max-width:720px;margin:0 0 30px;color:#fff;font-size:17px;line-height:1.65;}\n.sb-mal .hbtns{display:flex;flex-wrap:wrap;gap:14px;}\n.sb-mal .btn1{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:#18b7b2;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-mal .btn1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-mal .btn2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;background:transparent;border:2px solid #fff;color:#fff!important;text-decoration:none!important;text-transform:uppercase;font-size:13px;font-weight:900;letter-spacing:.6px;transition:all .25s;}\n.sb-mal .btn2:hover{background:#fff;color:#139b97!important;transform:translateY(-2px);}\n\/* WARN *\/\n.sb-mal .warn{background:rgba(245,166,35,.1);border-left:4px solid #f5a623;border-radius:10px;padding:18px 22px;margin-bottom:32px;font-size:14px;color:#555;line-height:1.7;}\n.sb-mal .warn strong{color:#111;display:block;margin-bottom:6px;font-size:15px;}\n\/* CARDS *\/\n.sb-mal .cards{display:grid;grid-template-columns:repeat(4,1fr);gap:22px;margin-bottom:48px;}\n.sb-mal .card{min-height:210px;padding:28px;border-radius:24px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);transition:all .25s;}\n.sb-mal .card:hover{background:#18b7b2;color:#fff;transform:translateY(-6px);box-shadow:0 18px 40px rgba(24,183,178,.22);}\n.sb-mal .card .num{display:inline-flex;margin-bottom:24px;color:#18b7b2;font-size:13px;font-weight:900;}\n.sb-mal .card:hover .num{color:#fff;}\n.sb-mal .card h3{margin:0 0 12px;color:inherit;font-size:18px;line-height:1.3;font-weight:900;}\n.sb-mal .card p{margin:0;color:inherit;font-size:14px;line-height:1.6;opacity:.88;}\n\/* 2-COL *\/\n.sb-mal .two{display:grid;grid-template-columns:1.1fr 0.9fr;gap:34px;margin-bottom:34px;}\n.sb-mal .two>div{padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-mal .two h2{margin:0 0 14px;color:#111;font-size:24px;font-weight:900;}\n.sb-mal .two h3{margin:0 0 14px;color:#111;font-size:20px;font-weight:900;}\n.sb-mal .two p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-mal .two ul{margin:0;padding:0;list-style:none;}\n.sb-mal .two li{position:relative;padding:10px 0 10px 22px;border-bottom:1px solid #eee;color:#555;font-size:14px;line-height:1.5;}\n.sb-mal .two li::before{content:\"\";position:absolute;left:0;top:18px;width:8px;height:8px;border-radius:50%;background:#18b7b2;}\n.sb-mal .two li a{color:#139b97!important;font-weight:700;text-decoration:none!important;}\n.sb-mal .two li a:hover{text-decoration:underline!important;}\n\/* SECTIONS *\/\n.sb-mal .sec{margin-bottom:34px;padding:34px;border-radius:26px;background:#fff;border:1px solid #eee;}\n.sb-mal .sec h2{margin:0 0 14px;color:#111;font-size:22px;font-weight:900;}\n.sb-mal .sec h3{margin:0 0 10px;color:#111;font-size:17px;font-weight:900;}\n.sb-mal .sec p{margin:0 0 12px;color:#555;font-size:15px;line-height:1.7;}\n.sb-mal .sec p:last-child{margin-bottom:0;}\n\/* TABLES *\/\n.sb-mal .tw{overflow-x:auto;margin-top:16px;}\n.sb-mal table{width:100%;border-collapse:collapse;font-size:14px;min-width:480px;}\n.sb-mal thead th{background:#18b7b2;color:#fff;padding:11px 13px;text-align:left;font-weight:700;}\n.sb-mal tbody tr:nth-child(even){background:#f5fffe;}\n.sb-mal tbody tr:hover{background:#e8f9f8;}\n.sb-mal tbody td{padding:10px 13px;vertical-align:top;border-bottom:1px solid #e5e5e5;line-height:1.5;font-size:13px;}\n.sb-mal table a{color:#18b7b2;text-decoration:none;font-weight:600;}\n.sb-mal table a:hover{color:#139b97;}\n\/* FAQ *\/\n.sb-mal .faq{margin-bottom:34px;padding:34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-mal .faq h2{margin:0 0 20px;color:#111;font-size:22px;font-weight:900;}\n.sb-mal .faq-item{border-bottom:1px solid #e0e0e0;padding:18px 0;}\n.sb-mal .faq-item:last-child{border-bottom:none;}\n.sb-mal .faq-q{font-size:15px;font-weight:900;color:#111;margin-bottom:8px;}\n.sb-mal .faq-a{font-size:14px;color:#555;line-height:1.7;}\n\/* RELATED *\/\n.sb-mal .related{margin-bottom:34px;padding:28px 34px;border-radius:26px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);}\n.sb-mal .related h3{margin:0 0 16px;color:#111;font-size:18px;font-weight:900;}\n.sb-mal .rel-grid{display:grid;grid-template-columns:repeat(2,1fr);gap:12px;}\n.sb-mal .rel-grid a{display:flex;align-items:center;min-height:50px;padding:12px 16px;border-radius:12px;background:#fff;border:1px solid #e0e0e0;color:#111!important;text-decoration:none!important;font-size:13px;font-weight:700;transition:all .2s;}\n.sb-mal .rel-grid a:hover{border-color:#18b7b2;color:#139b97!important;}\n\/* CTA *\/\n.sb-mal .cta{margin-top:16px;padding:54px 34px;border-radius:30px;background:#f7fbfb;border:1px solid rgba(24,183,178,.18);text-align:center;}\n.sb-mal .cta h2{margin:0 0 12px;color:#111;font-size:28px;font-weight:900;}\n.sb-mal .cta p{max-width:760px;margin:0 auto 26px;color:#555;font-size:15px;line-height:1.65;}\n.sb-mal .ctabtns{display:flex;flex-wrap:wrap;gap:14px;justify-content:center;}\n.sb-mal .ctab1,.sb-mal .ctab2{display:inline-flex;align-items:center;justify-content:center;min-height:46px;padding:0 28px;border-radius:999px;font-size:13px;font-weight:900;text-transform:uppercase;letter-spacing:.6px;text-decoration:none!important;transition:all .25s;}\n.sb-mal .ctab1{background:#18b7b2;color:#fff!important;}\n.sb-mal .ctab1:hover{background:#139b97;transform:translateY(-2px);}\n.sb-mal .ctab2{background:transparent;border:2px solid #18b7b2;color:#18b7b2!important;}\n.sb-mal .ctab2:hover{background:#18b7b2;color:#fff!important;transform:translateY(-2px);}\n@media(max-width:1100px){\n  .sb-mal .hero{padding:48px 36px;}\n  .sb-mal .cards{grid-template-columns:repeat(2,1fr);}\n  .sb-mal .two{grid-template-columns:1fr;}\n  .sb-mal .rel-grid{grid-template-columns:1fr;}\n}\n@media(max-width:700px){\n  .sb-mal{padding:50px 16px 70px;}\n  .sb-mal .hero{padding:40px 24px;border-radius:24px;}\n  .sb-mal .hero h1{font-size:25px;}\n  .sb-mal .hbtns{flex-direction:column;}\n  .sb-mal .btn1,.sb-mal .btn2{width:100%;}\n  .sb-mal .cards{grid-template-columns:1fr;}\n  .sb-mal .card{min-height:auto;padding:20px;}\n  .sb-mal .two>div,.sb-mal .sec,.sb-mal .faq{padding:20px;}\n  .sb-mal .cta{padding:36px 20px;}\n  .sb-mal .ctabtns{flex-direction:column;}\n  .sb-mal .ctab1,.sb-mal .ctab2{width:100%;}\n}\n<\/style>\n<div class=\"wrap\">\n  <div class=\"bc\">\n    <a href=\"http:\/\/seamlessbio.de\/\">Home<\/a><span>\/<\/span>\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\">Applications<\/a><span>\/<\/span>\n    <strong>Malaria &amp; Tropical Disease Research<\/strong>\n  <\/div>\n  <div class=\"hero\">\n    <span class=\"ey\">SeamlessBio \u2014 Solutions by Application<\/span>\n    <h1>Malaria &amp; Tropical Disease Research \u2014 Human Serum AB for Plasmodium falciparum Culture<\/h1>\n    <p class=\"sub\">Plasmodium falciparum in vitro culture is the cornerstone of malaria drug discovery, vaccine development, and parasite biology research. The Trager and Jensen protocol (1976) established human red blood cells and human serum as the required culture components \u2014 and this remains the standard today. SeamlessBio supplies Human Serum Type AB OTC for Plasmodium culture and Human Serum AB Heat Inactivated for PBMC-based immunological assays.<\/p>\n    <div class=\"hbtns\">\n      <a href=\"https:\/\/www.seamlessbio.de\/about-us\/contact-imprint\/\" class=\"btn1\">Contact Us<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"btn2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n  <div class=\"warn\"><strong>Why Type AB serum is required for Plasmodium culture:<\/strong> Plasmodium falciparum infects and replicates within human red blood cells. Anti-A and anti-B antibodies present in non-AB serum types cause agglutination and haemolysis of RBCs used in culture \u2014 destroying the host cells needed for parasite replication. Type AB serum contains no anti-A or anti-B antibodies and is the only blood group compatible with mixed RBC preparations from any donor.<\/div>\n  <div class=\"cards\"><div class=\"card\"><span class=\"num\">01<\/span><h3>Human Serum AB OTC \u2014 Plasmodium Culture<\/h3><p>The published standard (Trager &amp; Jensen 1976) for continuous P. falciparum culture. AB type \u2014 no RBC agglutination. Native OTC \u2014 complement intact for natural growth conditions. 5% in RPMI-1640.<\/p><\/div>\n<div class=\"card\"><span class=\"num\">02<\/span><h3>Human Serum AB HI \u2014 PBMC Assays<\/h3><p>For PBMC-based malaria immunology: ELISpot, cytokine assays, proliferation. Heat inactivated (56\u00b0C\/30 min) eliminates complement-mediated PBMC lysis during antigen stimulation.<\/p><\/div>\n<div class=\"card\"><span class=\"num\">03<\/span><h3>BSA Low Endotoxin \u2014 AlbuMAX Alternative<\/h3><p>BSA Low Endotoxin as base for AlbuMAX-equivalent serum-free P. falciparum culture. Used with lipid supplement at 0.5% equivalent concentration for defined conditions.<\/p><\/div>\n<div class=\"card\"><span class=\"num\">04<\/span><h3>Lot Reservation \u2014 Full Campaign Coverage<\/h3><p>Sorbitol synchronisation of P. falciparum requires 4\u20138 weeks of continuous culture in the same serum lot. SeamlessBio reserves dedicated lots for malaria research at no cost during the evaluation phase.<\/p><\/div><\/div>\n  <div class=\"two\">\n    <div>\n      <h2>AlbuMAX vs Human Serum AB \u2014 when to use which<\/h2>\n      <p>AlbuMAX (lipid-enriched BSA) supports P. falciparum growth and is used when defined serum-free conditions are required. However, <strong>Human Serum AB OTC remains the gold standard<\/strong> for parasitological assays where physiological serum conditions are important.<\/p><p>For <strong>drug susceptibility testing<\/strong> (DISA, RSA), Human Serum AB OTC is specifically required: human serum protein binding of antimalarial compounds (chloroquine, artemisinin, lumefantrine) is physiologically relevant. AlbuMAX underestimates protein binding and overestimates free drug concentration \u2014 leading to systematic errors in IC50 determination.<\/p><p>For <strong>routine passaging<\/strong> where defined conditions are acceptable and cost is the primary constraint, AlbuMAX provides lower lot-to-lot variability at lower cost. For assays that generate data for regulatory submissions or publication, Human Serum AB OTC is the appropriate choice.<\/p><p><strong>Lot reservation is essential for malaria research:<\/strong> P. falciparum synchronisation by sorbitol requires 4\u20138 weeks of continuous culture. A serum lot change mid-synchronisation disrupts parasite growth kinetics, invalidates synchrony, and requires restarting from frozen stocks. SeamlessBio holds reserved lots at no cost during the evaluation phase.<\/p>\n    <\/div>\n    <div>\n      <h3>Recommended products<\/h3>\n      <ul><li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab\">Human Serum AB OTC<\/a> \u2014 P. falciparum culture, drug susceptibility<\/li><li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab-male\">Human Serum AB OTC Male<\/a> \u2014 hormone-free, consistent OPKA<\/li><li><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male\">Human Serum AB HI<\/a> \u2014 PBMC ELISpot, malaria immunology<\/li><li><a href=\"https:\/\/www.seamlessbio.de\/products\/albumin-proteins\/bsa-low-endotoxin\">BSA Low Endotoxin<\/a> \u2014 AlbuMAX-equivalent base, lipid supplement<\/li><li><a href=\"https:\/\/www.seamlessbio.de\/products\/animal-sera\/guinea-pig-serum\">Guinea Pig Serum<\/a> \u2014 Complement fixation tests (CFT) \u2014 tropical disease serology<\/li><li><a href=\"https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin\">FBS Low Endotoxin<\/a> \u2014 Leishmania, Trypanosoma, Toxoplasma culture<\/li><\/ul>\n    <\/div>\n  <\/div>\n  <div class=\"sec\"><h2>Standard Protocol \u2014 Plasmodium falciparum Continuous Culture<\/h2><div class=\"tw\"><table><thead><tr><th>Parameter<\/th><th>Specification<\/th><\/tr><\/thead><tbody><tr><td>Base medium<\/td><td>RPMI-1640 + 25 mM HEPES + 0.2% NaHCO\u2083<\/td><\/tr><tr><td>Serum supplement<\/td><td>5% Human Serum Type AB OTC (Trager &amp; Jensen standard)<\/td><\/tr><tr><td>RBC source<\/td><td>Type O+ human erythrocytes \u2014 2\u20135% haematocrit<\/td><\/tr><tr><td>Atmosphere<\/td><td>5% CO\u2082 \/ 5% O\u2082 \/ 90% N\u2082 (candle jar or controlled gas mixture)<\/td><\/tr><tr><td>Temperature<\/td><td>37\u00b0C<\/td><\/tr><tr><td>Serum alternative<\/td><td>AlbuMAX I or II (lipid-rich BSA) \u2014 serum-free option for defined conditions<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class=\"sec\"><h2>Full Application Portfolio \u2014 Malaria &amp; Tropical Disease Research<\/h2><div class=\"tw\"><table><thead><tr><th>Application<\/th><th>Recommended Product<\/th><th>Protocol Note<\/th><\/tr><\/thead><tbody><tr><td><strong>P. falciparum continuous culture<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab'>Human Serum AB OTC native<\/a> \u2014 5%<\/td><td>Trager &amp; Jensen protocol. Native complement intact. AB type \u2014 no RBC lysis.<\/td><\/tr><tr><td><strong>Drug susceptibility assay<\/strong> (RSA, DISA)<\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab'>Human Serum AB OTC<\/a> \u2014 5%<\/td><td>Human serum protein binding of antimalarials is physiologically relevant. AlbuMAX overestimates free drug.<\/td><\/tr><tr><td><strong>PBMC stimulation \u2014 malaria antigens<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-type-ab-male'>Human Serum AB HI<\/a> \u2014 5\u201310%<\/td><td>HI eliminates complement-mediated PBMC lysis during antigen stimulation.<\/td><\/tr><tr><td><strong>IFN-\u03b3 ELISpot \u2014 vaccine immunogenicity<\/strong><\/td><td>Human Serum AB HI or FBS VLE \u22641 EU\/mL<\/td><td>Human Serum AB HI provides species-matched matrix for T cell responses to malaria antigens (RTS,S, R21).<\/td><\/tr><tr><td><strong>Opsonophagocytosis (OPKA)<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab'>Human Serum AB OTC native<\/a> \u2014 10\u201325%<\/td><td>Active human complement required. Human IgG + complement for physiological opsonisation of P. falciparum-infected RBCs.<\/td><\/tr><tr><td><strong>Leishmania \/ Trypanosoma culture<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin'>FBS Low Endotoxin \u22645 EU\/mL<\/a> \u2014 10\u201320%<\/td><td>SDM-79 (Leishmania), HMI-9 (Trypanosoma). Low Endotoxin reduces non-specific innate immune activation.<\/td><\/tr><tr><td><strong>Toxoplasma gondii infection assay<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/fetal-bovine-serum\/fbs-low-very-low-endotoxin'>FBS Low Endotoxin \u22645 EU\/mL<\/a> \u2014 10%<\/td><td>HFF or Vero host cells. Low Endotoxin reduces background cytokine in macrophage infection models.<\/td><\/tr><tr><td><strong>Complement fixation test (CFT)<\/strong><\/td><td><a href='https:\/\/www.seamlessbio.de\/products\/animal-sera\/guinea-pig-serum'>Guinea Pig Serum<\/a><\/td><td>Standard complement source for tropical disease serology \u2014 Brucella, Leishmania, Trypanosoma CFT diagnostics.<\/td><\/tr><\/tbody><\/table><\/div><\/div><div class=\"sec\"><h2>Human Serum AB OTC vs AlbuMAX \u2014 Comparison<\/h2><div class=\"tw\"><table><thead><tr><th>Parameter<\/th><th>Human Serum AB OTC<\/th><th>AlbuMAX I\/II<\/th><\/tr><\/thead><tbody><tr><td>Physiological relevance<\/td><td>\u2705 Native human serum \u2014 closest to in vivo conditions<\/td><td>Lipid-enriched BSA \u2014 defined but non-physiological<\/td><\/tr><tr><td>Drug susceptibility testing<\/td><td>\u2705 Correct protein binding of antimalarials<\/td><td>Overestimates free drug \u2014 underestimates protein binding<\/td><\/tr><tr><td>Lot-to-lot variability<\/td><td>Pooled donors \u2014 batch reservation minimises impact<\/td><td>Lower variability \u2014 defined composition<\/td><\/tr><tr><td>Complement activity<\/td><td>Active \u2014 relevant for some invasion and OPKA assays<\/td><td>No complement activity<\/td><\/tr><tr><td>Cost<\/td><td>Higher<\/td><td>Lower for routine passaging<\/td><\/tr><tr><td>Published standard<\/td><td>\u2705 Trager &amp; Jensen 1976 \u2014 WHO malaria reference protocol<\/td><td>Alternative \u2014 widely used for routine passaging<\/td><\/tr><\/tbody><\/table><\/div><\/div>\n  <div class=\"faq\"><h2>Frequently Asked Questions<\/h2><div class=\"faq-item\"><div class=\"faq-q\">Why must serum be Type AB for Plasmodium falciparum culture?<\/div><div class=\"faq-a\">P. falciparum replicates inside human red blood cells. Anti-A and anti-B antibodies present in Type A, B or O serum cause agglutination and haemolysis of the erythrocytes used as host cells \u2014 destroying the substrate for parasite replication. Type AB serum contains neither anti-A nor anti-B antibodies and is therefore compatible with RBC preparations from any blood group donor. This is the universal standard for P. falciparum continuous culture.<\/div><\/div><div class=\"faq-item\"><div class=\"faq-q\">Should native (OTC) or heat inactivated serum be used for Plasmodium culture?<\/div><div class=\"faq-a\">Native off-the-clot serum is standard for continuous P. falciparum culture and drug susceptibility assays \u2014 complement activity in native serum does not prevent parasite growth under standard culture conditions. Heat inactivated serum is used for PBMC-based immunological assays (ELISpot, proliferation, cytokine assays) where complement-mediated lysis of activated immune cells must be prevented.<\/div><\/div><div class=\"faq-item\"><div class=\"faq-q\">Is Human Serum AB available from EU donors?<\/div><div class=\"faq-a\">Yes \u2014 SeamlessBio supplies Human Serum Type AB OTC from EU-certified blood donor centres with full viral testing documentation (HIV, HBV, HCV, CMV, EBV, Parvovirus B19). EU and US origin both available. All lots include CoA, CoO and viral testing panel. Batch reservation available for extended malaria research programmes.<\/div><\/div><div class=\"faq-item\"><div class=\"faq-q\">How much serum do I need for a 12-month malaria research programme?<\/div><div class=\"faq-a\">A standard P. falciparum culture in 25 cm\u00b2 flasks at 10 mL per flask, with medium changes every 48 hours and 5% serum, requires approximately 90 mL of Human Serum AB OTC per flask per month. For 4\u20136 flasks running continuously, plan for 500\u2013600 mL per month \u2014 approximately 6\u20137 L per year. SeamlessBio recommends reserving 12 months' supply from a single lot to avoid synchrony disruption from lot changes.<\/div><\/div><\/div>\n  <div class=\"related\">\n    <h3>Related Applications &amp; Products<\/h3>\n    <div class=\"rel-grid\"><a href=\"https:\/\/www.seamlessbio.de\/applications\/pbmc-immunology\">\u2192 PBMC Immunology Assays<\/a><a href=\"https:\/\/www.seamlessbio.de\/applications\/cytotoxicity-assays\">\u2192 Cytotoxicity Assays<\/a><a href=\"https:\/\/www.seamlessbio.de\/products\/human-sera-plasma-and-more\/human-serum-off-the-clot-type-ab\">\u2192 Human Serum AB OTC<\/a><a href=\"https:\/\/www.seamlessbio.de\/products\/animal-sera\/guinea-pig-serum\">\u2192 Guinea Pig Serum \u2014 CFT complement<\/a><\/div>\n  <\/div>\n  <!-- HUB BACKLINK -->\n  <div style=\"text-align:center;padding:20px 0 0;border-top:1px solid rgba(24,183,178,.15);margin-bottom:16px;\">\n    <a href=\"https:\/\/www.seamlessbio.de\/applications\/\" style=\"display:inline-flex;align-items:center;gap:8px;color:#18b7b2;font-size:14px;font-weight:700;text-decoration:none;\">\n      \u2190 All Application Guides Overview\n    <\/a>\n  <\/div>\n\n  <div class=\"cta\">\n    <h2>Lot Reservation for Malaria Research Programmes<\/h2>\n    <p>Human Serum AB OTC lot reservation \u2014 6-week no-cost hold. Viral testing documentation (HIV, HBV, HCV, CMV, EBV, PVB19) per lot on request.<br>Email: info@seamlessbio.de | +49 851 37932226<\/p>\n    <div class=\"ctabtns\">\n      <a href=\"mailto:info@seamlessbio.de\" class=\"ctab1\">Contact Us<\/a>\n      <a href=\"https:\/\/shop.seamlessbio.de\" class=\"ctab2\">View in Shop<\/a>\n    <\/div>\n  <\/div>\n<\/div>\n<script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"FAQPage\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/malaria-tropical-disease-research#faqpage\",\n      \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Why must serum be Type AB for Plasmodium falciparum culture?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"P. falciparum replicates inside human red blood cells. Anti-A and anti-B antibodies present in Type A, B or O serum cause agglutination and haemolysis of the erythrocytes used as host cells \u2014 destroying the substrate for parasite replication. Type AB serum contains neither anti-A nor anti-B antibodies and is therefore compatible with RBC preparations from any blood group donor. This is the universal standard for P. falciparum continuous culture.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Should native (OTC) or heat inactivated serum be used for Plasmodium culture?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Native off-the-clot serum is standard for continuous P. falciparum culture and drug susceptibility assays \u2014 complement activity in native serum does not prevent parasite growth under standard culture conditions. Heat inactivated serum is used for PBMC-based immunological assays (ELISpot, proliferation, cytokine assays) where complement-mediated lysis of activated immune cells must be prevented.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Human Serum AB available from EU donors?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes \u2014 SeamlessBio supplies Human Serum Type AB OTC from EU-certified blood donor centres with full viral testing documentation (HIV, HBV, HCV, CMV, EBV, Parvovirus B19). EU and US origin both available. All lots include CoA, CoO and viral testing panel. Batch reservation available for extended malaria research programmes.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How much serum do I need for a 12-month malaria research programme?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"A standard P. falciparum culture in 25 cm\u00b2 flasks at 10 mL per flask, with medium changes every 48 hours and 5% serum, requires approximately 90 mL of Human Serum AB OTC per flask per month. For 4\u20136 flasks running continuously, plan for 500\u2013600 mL per month \u2014 approximately 6\u20137 L per year. SeamlessBio recommends reserving 12 months' supply from a single lot to avoid synchrony disruption from lot changes.\"\n      }\n    }\n      ]\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/www.seamlessbio.de\/applications\/malaria-tropical-disease-research#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"name\": \"Home\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"name\": \"Applications\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/\"\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 3,\n          \"name\": \"Malaria & Tropical Disease Research\",\n          \"item\": \"https:\/\/www.seamlessbio.de\/applications\/malaria-tropical-disease-research\"\n        }\n      ]\n    }\n  ]\n}\n<\/script>\n<\/section>\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home\/ Applications\/ Malaria &amp; Tropical Disease Research SeamlessBio \u2014 Solutions by Application Malaria &amp; Tropical Disease Research \u2014 Human Serum AB for Plasmodium falciparum Culture Plasmodium falciparum in vitro culture [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_eb_attr":"","footnotes":""},"class_list":["post-708","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Malaria &amp; Tropical Disease Research \u2014 Serum for Cell Culture<\/title>\n<meta name=\"description\" content=\"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/malaria-tropical-disease-research\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Malaria &amp; Tropical Disease Research \u2014 Serum for Cell Culture\" \/>\n<meta property=\"og:description\" content=\"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/malaria-tropical-disease-research\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-27T11:06:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"6\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/malaria-tropical-disease-research\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/malaria-tropical-disease-research\\\/\",\"name\":\"Malaria & Tropical Disease Research \u2014 Serum for Cell Culture\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-05-14T15:20:42+00:00\",\"dateModified\":\"2026-06-27T11:06:49+00:00\",\"description\":\"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/malaria-tropical-disease-research\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/malaria-tropical-disease-research\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/malaria-tropical-disease-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/seamlessbio.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Application Malaria Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png\",\"width\":309,\"height\":88,\"caption\":\"SeamlessBio\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Malaria & Tropical Disease Research \u2014 Serum for Cell Culture","description":"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/malaria-tropical-disease-research\/","og_locale":"de_DE","og_type":"article","og_title":"Malaria & Tropical Disease Research \u2014 Serum for Cell Culture","og_description":"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.","og_url":"https:\/\/seamlessbio.de\/de\/malaria-tropical-disease-research\/","og_site_name":"SeamlessBio","article_modified_time":"2026-06-27T11:06:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"6\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/malaria-tropical-disease-research\/","url":"https:\/\/seamlessbio.de\/malaria-tropical-disease-research\/","name":"Malaria & Tropical Disease Research \u2014 Serum for Cell Culture","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-05-14T15:20:42+00:00","dateModified":"2026-06-27T11:06:49+00:00","description":"Human Serum AB OTC for Plasmodium falciparum in vitro culture (Trager-Jensen). Drug susceptibility testing, PBMC ELISpot, OPA, Comparison.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/malaria-tropical-disease-research\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/malaria-tropical-disease-research\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/seamlessbio.de\/malaria-tropical-disease-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/seamlessbio.de\/"},{"@type":"ListItem","position":2,"name":"Application Malaria Research"}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Expert for biological materials for pharma, vaccines and research organizations","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/cropped-cropped-cropped-\u0438\u0437\u043e\u0431\u0440\u0430\u0436\u0435\u043d\u0438\u0435_2026-04-26_165903047.png","width":309,"height":88,"caption":"SeamlessBio"},"image":{"@id":"https:\/\/seamlessbio.de\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=708"}],"version-history":[{"count":13,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/708\/revisions"}],"predecessor-version":[{"id":1809,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/pages\/708\/revisions\/1809"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}